DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Pridopidine is an investigational drug.
There have been 9 clinical trials for Pridopidine. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2008.
The most common disease conditions in clinical trials are Huntington Disease, Amyotrophic Lateral Sclerosis, and Parkinson Disease. The leading clinical trial sponsors are Teva Branded Pharmaceutical Products, R&D Inc., Teva Pharmaceutical Industries, and Huntington Study Group.
Recent Clinical Trials for Pridopidine
|HEALEY ALS Platform Trial - Regimen D Pridopidine||Prilenia Therapeutics||Phase 2/Phase 3|
|HEALEY ALS Platform Trial - Regimen D Pridopidine||Merit E. Cudkowicz, MD||Phase 2/Phase 3|
|PRidopidine's Outcome On Function in Huntington Disease, PROOF- HD||Prilenia||Phase 3|